MR spectroscopy in stroke

Area of Science:

• Neuroscience
• Biochemistry
• Medical Imaging

Background:

• Magnetic resonance spectroscopy (MRS) is a non-invasive technique for studying in vivo biochemical changes.
• MRS has been applied to investigate intracellular metabolism during cerebral ischemia in stroke.
• Proton [1H]-MRS is commonly used, detecting markers like N-acetyl aspartate (NAA).

Purpose of the Study:

• To investigate biochemical changes in the brain using MRS in stroke patients.
• To assess the utility of [1H]-MRS in monitoring ischemic injury progression.
• To explore the role of MRS in predicting stroke patient mortality and treatment response.

Main Methods:

• Utilizing proton [1H]-MRS to detect and quantify metabolites in the brain.
• Comparing metabolite concentrations (NAA, creatine, lactate) between infarcted and contralateral hemispheres.
• Conducting longitudinal studies to track changes over time post-infarction.

Main Results:

• [1H]-MRS revealed increased lactate and reduced NAA and total creatine in human stroke infarcts compared to healthy tissue.
• Longitudinal studies indicated a continued decrease in NAA for over a week, suggesting ongoing ischemic injury.
• In small infarcts (<80 cm3), NAA concentrations and cerebral blood flow helped identify patients who might benefit from new drug treatments.

Conclusions:

• [1H]-MRS provides valuable insights into the biochemical dynamics of cerebral ischemia.
• MRS metabolite changes correlate with infarct severity and can indicate ongoing injury.
• MRS parameters, combined with other measures, can aid in personalized stroke treatment strategies.